147 related articles for article (PubMed ID: 9407708)
1. Controversies about iron in parkinsonian and control substantia nigra.
Gałazka-Friedman J; Friedman A
Acta Neurobiol Exp (Wars); 1997; 57(3):217-25. PubMed ID: 9407708
[TBL] [Abstract][Full Text] [Related]
2. Iron dysregulation and Parkinson's disease.
Andersen JK
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S47-52. PubMed ID: 15665414
[TBL] [Abstract][Full Text] [Related]
3. Mössbauer spectroscopy and ELISA studies reveal differences between Parkinson's disease and control substantia nigra.
Galazka-Friedman J; Bauminger ER; Koziorowski D; Friedman A
Biochim Biophys Acta; 2004 Mar; 1688(2):130-6. PubMed ID: 14990343
[TBL] [Abstract][Full Text] [Related]
4. Iron as a cause of Parkinson disease - a myth or a well established hypothesis?
Friedman A; Galazka-Friedman J; Koziorowski D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S212-4. PubMed ID: 20082993
[TBL] [Abstract][Full Text] [Related]
5. Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.
Sofic E; Riederer P; Heinsen H; Beckmann H; Reynolds GP; Hebenstreit G; Youdim MB
J Neural Transm; 1988; 74(3):199-205. PubMed ID: 3210014
[TBL] [Abstract][Full Text] [Related]
6. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
7. Iron transport in Parkinson's disease.
Hirsch EC
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S209-11. PubMed ID: 20082992
[TBL] [Abstract][Full Text] [Related]
8. Potential sources of increased iron in the substantia nigra of parkinsonian patients.
Gerlach M; Double KL; Youdim MB; Riederer P
J Neural Transm Suppl; 2006; (70):133-42. PubMed ID: 17017520
[TBL] [Abstract][Full Text] [Related]
9. Ventral posterior substantia nigra iron increases over 3 years in Parkinson's disease.
Bergsland N; Zivadinov R; Schweser F; Hagemeier J; Lichter D; Guttuso T
Mov Disord; 2019 Jul; 34(7):1006-1013. PubMed ID: 31180615
[TBL] [Abstract][Full Text] [Related]
10. The history of the research of iron in parkinsonian substantia nigra.
Friedman A; Galazka-Friedman J
J Neural Transm (Vienna); 2012 Dec; 119(12):1507-10. PubMed ID: 22941506
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
Reimão S; Ferreira S; Nunes RG; Pita Lobo P; Neutel D; Abreu D; Gonçalves N; Campos J; Ferreira JJ
Eur J Neurol; 2016 Feb; 23(2):368-74. PubMed ID: 26518135
[TBL] [Abstract][Full Text] [Related]
12. Impaired iron homeostasis in Parkinson's disease.
Double KL; Gerlach M; Youdim MB; Riederer P
J Neural Transm Suppl; 2000; (60):37-58. PubMed ID: 11205155
[TBL] [Abstract][Full Text] [Related]
13. Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.
Ayton S; Lei P
Biomed Res Int; 2014; 2014():581256. PubMed ID: 24527451
[TBL] [Abstract][Full Text] [Related]
14. XANES spectroscopy of a single neuron from a patient with Parkinson's disease.
Yoshida S; Ektessabi A; Fujisawa S
J Synchrotron Radiat; 2001 Mar; 8(Pt 2):998-1000. PubMed ID: 11513007
[TBL] [Abstract][Full Text] [Related]
15. Genetics of iron regulation and the possible role of iron in Parkinson's disease.
Rhodes SL; Ritz B
Neurobiol Dis; 2008 Nov; 32(2):183-95. PubMed ID: 18675357
[TBL] [Abstract][Full Text] [Related]
16. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?
Youdim MB; Ben-Shachar D; Riederer P
Acta Neurol Scand Suppl; 1989; 126():47-54. PubMed ID: 2618593
[TBL] [Abstract][Full Text] [Related]
17. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease.
Gorell JM; Ordidge RJ; Brown GG; Deniau JC; Buderer NM; Helpern JA
Neurology; 1995 Jun; 45(6):1138-43. PubMed ID: 7783878
[TBL] [Abstract][Full Text] [Related]
18. Iron accumulation in Parkinson's disease.
Mochizuki H; Yasuda T
J Neural Transm (Vienna); 2012 Dec; 119(12):1511-4. PubMed ID: 23070727
[TBL] [Abstract][Full Text] [Related]
19. Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility.
Martin-Bastida A; Lao-Kaim NP; Loane C; Politis M; Roussakis AA; Valle-Guzman N; Kefalopoulou Z; Paul-Visse G; Widner H; Xing Y; Schwarz ST; Auer DP; Foltynie T; Barker RA; Piccini P
Eur J Neurol; 2017 Feb; 24(2):357-365. PubMed ID: 27982501
[TBL] [Abstract][Full Text] [Related]
20. Selective increase of iron in substantia nigra zona compacta of parkinsonian brains.
Sofic E; Paulus W; Jellinger K; Riederer P; Youdim MB
J Neurochem; 1991 Mar; 56(3):978-82. PubMed ID: 1704426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
